mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
SGX-523 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.7 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |